B
BIO
Bio Rad Labs Inc
279.99
+1.63+0.59%After Hours: 279.99 0.00 0.00%17:23 04/02 EDT
OPEN/PREV CLOSE275.31/278.36
TODAY RANGE274.08-284.45
VOL253.68K
MARKET CAP7.56B
52 WEEK RANGE211.43-343.12
AVG VOL (3M)290.89K
% TURNOVER0.94%
TURNOVER--
P/E (TTM)10.05
% RANGE3.62%
EPS(TTM)27.85
P/E(FORWARD)29.38
P/B1.014
BVPS276.16
DIVIDEND--
P/S2.925
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.16B
SHARES OUTSTANDING26.99M
NEXT EARNINGS04/29-05/04
FREE FLOAT18.44M
LOT SIZE1
EX-DATE03/08/2002
News
Press Releases
Financial Reports
Profile
NASDAQ·03/27 15:30
Why Is Agilent (A) Down 6.2% Since Last Earnings Report?
Simply Wall St·03/03 19:30
Assessing Bio-Rad (BIO) Valuation After Mixed Share Price Performance And Recurring Revenue Shift
Simply Wall St·02/27 22:33
Is It Time To Reconsider Bio-Rad Laboratories (BIO) After Its Prolonged Share Price Slump
Simply Wall St·02/24 15:28
A Look At Bio Rad Laboratories (BIO) Valuation After Recent Share Price Weakness
TipRanks·02/19 22:20
Bio-Rad Updates Investors on Sartorius Strategic Investment Metrics
TipRanks·02/16 12:45
Bio-Rad price target lowered to $320 from $340 at Wells Fargo
Simply Wall St·02/15 06:29
Assessing Bio-Rad (BIO) Valuation After Recent Share Price Weakness And Longer-Term Return Pressures
TipRanks·02/14 00:10
Bio-Rad Laboratories Balances Growth Hopes With Margin Strain
Simply Wall St·02/13 23:23
Bio Rad Laboratories Q3 Loss Of US$12.70 EPS Tests Recovery Narrative For BIO Stock
Dow Jones·02/13 17:19
Bio-Rad Labs Shares Fall As Tight Research Funding Squeezes Margins
NASDAQ·02/13 16:57
Oversold Conditions For Bio-Rad Laboratories (BIO)
NASDAQ·02/13 16:06
Bio-Rad Laboratories (BIO) Shares Cross Below 200 DMA
Barchart·02/13 15:34
Stocks Settle Slightly Higher as Bond Yields Fall
TipRanks·02/13 14:35
Bio-Rad price target lowered to $335 from $350 at UBS
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.